Abstract
Background and aim
Recently, there has been an increased focus on the role nutrition and diet play in maintaining health in inflammatory bowel disease (IBD). We aimed to assess the overall quality, strength, and transparency of conflicts among guidelines on nutrition/diet in IBD.
Methods
A systematic search was performed on multiple databases from inception until January 1, 2021, to identify guidelines pertaining to nutrition or diet in IBD. All guidelines were reviewed for disclosure of conflicts of interest (COI) and funding, recommendation quality and strength, external document review, patient representation, and plans for update—as per Institute of Medicine (IOM) standards. In addition, recommendations and their quality were compared between guidelines/societies.
Results
Seventeen distinct societies and a total of 228 recommendations were included. Not all guidelines provided recommendations on key aspects of diet—such as the role of supplements or the appropriate micro/macro nutrition in IBD. Fifty-nine percent of guidelines reported on COI, 24% underwent external review, and 41% included patient representation. 18.4%, 25.9%, and 55.7% of recommendations were based on high-, moderate-, and low-quality evidence, respectively. 10.5%, 24.6%, and 64.9% of recommendations were strong, weak/conditional, and did not provide a strength, respectively. The proportion of high-quality evidence (p = 0.12) and strong recommendations (p = 0.83) did not significantly differ across societies.
Conclusions
Many guidelines do not provide recommendations on key aspects of diet/nutrition in IBD. As over 50% of recommendations are based on low-quality evidence, further studies on nutrition/diet in IBD are warranted to improve the overall quality of evidence.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study can be obtained from the corresponding author upon request.
References
Lichtenstein GR Jr, EVL, Isaacs KL, Regueiro MD, Gerson LB (2018) ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol 113:37
Kaplan GG (2015) The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol 12:720–727
Shivashankar R, Lewis JD (2017) The role of diet in inflammatory bowel disease. Curr Gastroenterol Rep 19:22
Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD (2020) Nutrition, IBD and gut microbiota: a review. Nutrients 12
Kakodkar S, Mutlu EA (2017) Diet as a therapeutic option for adult inflammatory bowel disease. Gastroenterol Clin North Am 46:745–767
Ledder O (2019) Antibiotics in inflammatory bowel diseases: do we know what we’re doing? Transl Pediatr 8:42–55
Emamie AD, Rajabpour M, Ghanavati R, Asadolahi P, Farzi S, Sobouti B, Darbandi A (2021) The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009–2020. J Appl Microbiol. [cited 2021 Jan 8]. Available from: https://sfamjournals.onlinelibrary.wiley.com/doi/abs/. https://doi.org/10.1111/jam.14907
Su GL, Ko CW, Bercik P, Falck-Ytter Y, Sultan S, Weizman AV, Morgan RL (2020) AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology 159:697–705
Ran Z, Wu K, Matsuoka K, Jeen YT, Wei SC, Ahuja V, Chen M, Hu P, Andoh A, Kim HJ et al (2020) Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia. J Gastroenterol Hepatol jgh.15185
Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, Sudhakar R, Singh A, Kumar A, Puri AS et al (2019) Diet and inflammatory bowel disease: the Asian Working Group guidelines. Indian J Gastroenterol 38:220–246
Lee J, Allen R, Ashley S, Becker S, Cummins P, Gbadamosi A, Gooding O, Huston J, Le Couteur J, O’Sullivan D et al (2014) British dietetic association evidence-based guidelines for the dietary management of Crohn’s disease in adults. J Hum Nutr Diet 27:207–218
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C et al (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:s1-106
Consensus guidelines for the management of inflammatory bowel disease (2010) Arq Gastroenterol 47:313–25
Mack DR, Benchimol EI, Critch J, deBruyn J, Tse F, Moayyedi P, Church P, Deslandres C, El-Matary W, Huynh H et al (2019) Canadian association of gastroenterology clinical practice guideline for the medical management of pediatric luminal Crohn’s disease. Gastroenterology 157:320–348
Torres J, Ellul P, Langhorst J, Mikocka-Walus A, Barreiro-de Acosta M, Basnayake C, Ding NJS, Gilardi D, Katsanos K, Moser G et al (2019) European Crohn’s and colitis organisation topical review on complementary medicine and psychotherapy in inflammatory bowel disease. Journal of Crohn’s and Colitis 13:673–685e
Bischoff SC, Escher J, Hébuterne X, Kłęk S, Krznaric Z, Schneider S, Shamir R, Stardelova K, Wierdsma N, Wiskin AE et al (2020) ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr 39:632–653
Authors, Collaborators (2019) Updated S3-guideline ulcerative colitis. German Society for Digestive and Metabolic Diseases (DGVS). Z Gastroenterol 57:162–241
Clinical update for general practitioners and physicians - inflammatory bowel disease 4th Edition (2018). Gastroenterol Soc Aust. [cited 2021 Jan 9]. Available from: https://www.gesa.org.au/resources/clinical-guidelines-and-updates/inflammatory-bowel-disease/
Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, Gasche C, Silverberg MS, Mahadevan U, Boneh RS et al (2020) Dietary guidance from the international organization for the study of inflammatory bowel diseases. Clin Gastroenterol Hepatol 18:1381–1392
Ramakrishna BS, Makharia GK, Abraham P, Ghoshal UC, Jayanthi V, Agarwal BK, Ahuja V, Bhasin DK, Bhatia SJ, Choudhuri G et al (2012) Indian Society of Gastroenterology consensus on ulcerative colitis. Indian J Gastroenterol 31:307–323
Ramakrishna BS, Makharia GK, Ahuja V, Ghoshal UC, Jayanthi V, Perakath B, Abraham P, Bhasin DK, Bhatia SJ, Choudhuri G et al (2015) Indian Society of Gastroenterology consensus statements on Crohn’s disease in India. Indian J Gastroenterol 34:3–22
Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, Kato J, Kobayashi K, Kobayashi K, Koganei K et al (2018) Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol 53:305–353
Yamamoto-Furusho JK, Gutiérrez-Grobe Y, López-Gómez JG, Bosques-Padilla F, Rocha-Ramírez JL (2018) Consenso mexicano para el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática. Rev Gastroenterol Mex 83:144–167
Yamamoto-Furusho JK, Bosques-Padilla F, Daffra P, De Paula JA, Etchevers J, Galiano MT, Ibañez P, Juliao F, Kotze PG, Marroquín de la Garza JM et al (2017) Situaciones especiales en la enfermedad inflamatoria intestinal: primer consenso latinoamericano de la Pan American Crohn’s and Colitis Organisation (PANCCO) (Segunda parte). Revista de Gastroenterología de México 82:134–55
Bernstein CN, Eliakim A, Fedail S, Fried M, Gearry R, Goh K-L, Hamid S, Khan AG, Khalif I, Ng SC et al (2016) World gastroenterology organisation global guidelines inflammatory bowel disease: update August 2015. J Clin Gastroenterol 50:803–818
Tremaine WJ, Petterson TM (2001) A prospective cohort study of practice guidelines in inflammatory bowel disease 96:6
Tricoci P (2009) Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 301:831
Rowe IA, Parker R, Armstrong MJ, King AL, Houlihan DD, Mutimer D (2012) Assessment of the quality of evidence underlying international guidelines in liver disease: American Journal of Gastroenterology 107:1276–1282
Lee DH, Vielemeyer O (2011) Analysis of overall level of evidence behind infectious diseases society of America practice guidelines. Arch Intern Med 171. [cited 2021 Jan 9]. Available from: http://archinte.jamanetwork.com/article.aspx?. https://doi.org/10.1001/archinternmed.2010.482
Sardar P, Giri J, Jaff MR, Parikh SA, Kundu A, White CJ, Chatterjee S, Kennedy KF, Desai NR, Hyder ON, et al. Strength of evidence underlying the American Heart Association/American College of Cardiology guidelines on endovascular and surgical treatment of peripheral vascular disease. Circ Cardiovasc Interv 12. [cited 2021 Jan 9]. Available from: https://www.ahajournals.org/doi/. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007244
Duarte-García A, Zamore R, Wong JB (2018) The evidence basis for the American College of Rheumatology practice guidelines. JAMA Intern Med 178:146
Feuerstein JD, Akbari M, Gifford AE, Cullen G, Leffler DA, Sheth SG, Cheifetz AS (2013) Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines. Aliment Pharmacol Ther 37:937–946
Institute of Medicine (US) Committee on Clinical Practice Guidelines (1992) Guidelines for clinical practice: from development to use [Internet]. Field MJ, Lohr KN, editors. Washington (DC): National Academies Press (US). [cited 2021 Jan 9]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK234503/
Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines (2011) Clinical practice guidelines we can trust [Internet]. Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, editors. Washington (DC): National Academies Press (US). [cited 2021 Jan 9]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK209539/
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535–b253
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E et al (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. Br Med J Publ Group 358:j4008
Makarski J, Brouwers MC, AGREE Enterprise (2014) The AGREE enterprise: a decade of advancing clinical practice guidelines. Implement Sci 9:103
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, deBeer H et al (2011) GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383–94
Oxford Centre for Evidence-Based Medicine: levels of evidence (2009) Centre for Evidence-Based Medicine (CEBM), University of Oxford. Oxford Centre for Evidence-Based Medicine. [cited 2021 Jan 9]. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Potential benefits, limitations, and harms of clinical guidelines. BMJ 318:527–530
Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, Tavazzi L, Poole-Wilson P, Le Pen C (2005) Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 26:1653–1659
Proietti M, Nobili A, Raparelli V, Napoleone L, Mannucci PM, Lip GYH (2016) Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study. Clin Res Cardiol 105:912–920
Wilke M, Grube RF, Bodmann KF (2011) Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy. Eur J Med Res 16:315–323
Wöckel A, Kurzeder C, Geyer V, Novasphenny I, Wolters R, Wischnewsky M, Kreienberg R, Varga D (2010) Effects of guideline adherence in primary breast cancer–A 5-year multi-center cohort study of 3976 patients. The Breast 19:120–127
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD (2019) ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol 114:384–413
Feuerstein JD, Akbari M, Gifford AE, Hurley CM, Leffler DA, Sheth SG, Cheifetz AS (2014) Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines. Mayo Clin Proc 89:16–24
Hazlehurst JM, Armstrong MJ, Sherlock M, Rowe IA, O’Reilly MW, Franklyn JA, Stewart PM, Tomlinson JW (2013) A comparative quality assessment of evidence-based clinical guidelines in endocrinology. Clin Endocrinol 78:183–190
Ducis K, Florman JE, Rughani AI (2016) Appraisal of the quality of neurosurgery clinical practice guidelines. World Neurosurgery 90:322–339
Venus C, Jamrozik E (2020) Evidence-poor medicine: just how evidence-based are Australian clinical practice guidelines? Intern Med J 50:30–37
Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schünemann HJ (2008) Going from evidence to recommendations. BMJ 336:1049–1051
Shekelle P, Eccles MP, Grimshaw JM, Woolf SH (2001) When should clinical guidelines be updated? BMJ 323:155–157
Vernooij RW, Sanabria AJ, Solà I, Alonso-Coello P, Martínez GL (2014) Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks. Implement Sci 9:3
Author information
Authors and Affiliations
Contributions
Simcha Weissman, Brian M. Fung, and Ayrton Bangolo searched the literature, wrote, and revised the manuscript. Atif Rashid, Badar F. Khan, Aditya K. Gudimella Tirumala, Sneha Nagpaul, Samuel Cornwell, Praveena Karamthoti, Vignesh Murugan, Ihsan S. Taranichi, Maksim Kalinin, Annetta Wishart, Ibtihal Khalaf, Naga A. Kodali, Pruthvi S.C. Aluri, Yabets Kejela, Rub Abdul, Feba M. Jacob, Advaith Manoharasetty, Aparna Sethi, Preethi M. Nadimpallli, Natalia P. Ballestas, Aarushi Venkatraman, Avinash Chirumamilla, Vignesh K. Nagesh, Manesh K. Gangwani, Kelly Issokson, Muhammad Aziz, and Arun Swaminath revised and edited the manuscript. Joseph D. Feuerstein revised and approved the final version and is the article’s guarantor. All authors certify that they contributed sufficiently to the intellectual content and data analysis. Each author has reviewed the final version of the manuscript and approves it for publication.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
384_2023_4404_MOESM1_ESM.tif
Supplementary Fig. 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement diagram delineating the process by which manuscripts were screened and ultimately included in this study (DOC 86 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Weissman, S., Fung, B.M., Bangolo, A. et al. The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease. Int J Colorectal Dis 38, 98 (2023). https://doi.org/10.1007/s00384-023-04404-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s00384-023-04404-x